SAMSUNG ELECTRONICS CO., LTD. et al. v. iCashe, Inc.

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care and DexCom have filed a joint motion to terminate IPR2024-00853 after reaching a confidential settlement and license agreement, invoking 35 U.S.C. § 317(a). The Board has not yet decided the merits, and the parties seek to end the proceeding.

Aardevo North America, LLC et al.vsAgventure B.V.

Aardevo North America petitions the PTAB Director to review the Board’s denial to institute an IPR on Agventure’s hybrid seed potato breeding patent. The petitioner contends the Board ignored printed‑publication anticipations, dismissed secondary‑consideration evidence, and misapplied the nexus requirement.

Suzhou Mojawa Intelligent Electronic Co., Ltd.vsShenzhen Shokz Co., Ltd.

The PTAB institution decision found a reasonable likelihood of success for the petitioner in challenging numerous claims of bone conduction headphone technology based on obviousness (35 U.S.C. § 103). The Board adopted the petitioner's definition of the level of ordinary skill, finding sufficient grounds to proceed with the IPR against Shenzhen Shokz Co., Ltd.

Rocket Media, LLC d/b/a Launch LabsvsFullthrottle Technologies, LLC et al.

Fullthrottle Technologies contests Rocket Media’s IPR petition targeting claims 1‑36 of its ’219 patent. The owner argues the cited prior art fails to teach essential claim limitations and lacks a motivation to combine, and urges denial under § 314(a) due to parallel district‑court litigation.

Capital One, National Association et al.vs--

Capital One National Association filed an IPR challenging Implicit, LLC's patent 8056075 on grounds of obviousness (35 U.S.C. §103). The petition asserts that the claims are rendered unpatentable by various combinations of prior art references including Fowlow and Kimera.